Macquarie Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $15.1M | Sell |
|
|||||
|
2024
Q1 | $36.9M | Sell |
|
|||||
|
2023
Q4 | $43.8M | Sell |
|
|||||
|
2023
Q3 | $66.1M | Sell |
|
|||||
|
2023
Q2 | $66.6M | Sell |
|
|||||
|
2023
Q1 | $61.9M | Sell |
|
|||||
|
2022
Q4 | $62.2M | Sell |
|
|||||
|
2022
Q3 | $60.9M | Sell |
|
|||||
|
2022
Q2 | $69.1M | Sell |
|
|||||
|
2022
Q1 | $73.3K | Buy |
|
|||||
|
2021
Q4 | $70.5M | Buy |
|
|||||
|
2021
Q3 | $63.7M | Sell |
|
|||||
|
2021
Q2 | $71.6M | Buy |
|
|||||
|
2021
Q1 | $61.3M | Buy |
|
|||||
|
2020
Q4 | $57.2M | Sell |
|
|||||
|
2020
Q3 | $54.8M | Sell |
|
|||||
|
2020
Q2 | $58.1M | Sell |
|
|||||
|
2020
Q1 | $68.8M | Sell |
|
|||||
|
2019
Q4 | $82.2M | Sell |
|
|||||
|
2019
Q3 | $76.2M | Sell |
|
|||||
|
2019
Q2 | $82.3M | Sell |
|
|||||
|
2019
Q1 | $87.6M | Sell |
|
|||||
|
2018
Q4 | $79.3M | Sell |
|
|||||
|
2018
Q3 | $80.3M | Sell |
|
|||||
|
2018
Q2 | $73M | Sell |
|
|||||
|
2018
Q1 | $79M | Sell |
|
|||||
|
2017
Q4 | $96.6M | Sell |
|
|||||
|
2017
Q3 | $100M | Sell |
|
|||||
|
2017
Q2 | $97.7M | Buy |
|
|||||
|
2017
Q1 | $74M | Buy |
|
|||||
|
2016
Q4 | $71.4M | Sell |
|
|||||
|
2016
Q3 | $115M | Sell |
|
|||||
|
2016
Q2 | $247M | Buy |
|
|||||
|
2016
Q1 | $104M | Buy |
|
|||||
|
2015
Q4 | $120M | Sell |
|
|||||
|
2015
Q3 | $153M | Buy |
|
|||||
|
2015
Q2 | $162M | Sell |
|
|||||
|
2015
Q1 | $184M | Sell |
|
|||||
|
2014
Q4 | $176M | Sell |
|
|||||
|
2014
Q3 | $192M | Sell |
|
|||||
|
2014
Q2 | $198M | Buy |
|
|||||
|
2014
Q1 | $174M | Buy |
|
|||||
|
2013
Q4 | $160M | Buy |
|
|||||
|
2013
Q3 | $146M | Sell |
|
|||||
|
2013
Q2 | $135M | Buy |
|